language arrow_drop_down
DK NO SE

Archive News


  •

    Prevas enters into agreement to acquire Evotech and the remaining minority shares in Tritech Technology and Deva Mecaneyes.

    Prevas has today entered into an agreement for the acquisition of all shares in the consulting company group Evotech and the remaining minority shares in the operational subsidiaries Tritech Technology and Deva Mecaneyes. The agreement is conditional subject to decision at the Prevas extraordinary general meeting. With the acquisition, an extremely strengthened position in product and production development is achieved.Acquired shares are valued at a total of approximately SEK 270 million and payment will be made through a combination of shares in Prevas issued through a non-cash issue and cash.
    Read more

References

  • Nipro Medical Europe

    Prevas UX/UI-expertise helps Nipro choose the right solutions within new design concept

  • Moelven

    Automated planning frees resources at Moelven

  • Gradientech

    Ultra-fast diagnostics system can save lives and counteract antibiotic resistance

  • 4Life Solutions

    Clean drinking water in four hours